Search Results 161-170 of 4292 for ✍올인구조대 [원탑보증.com/가입코드 111] sbc가입코드 ✍

  1. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    About this study. To study the safety and side effects of Ofatumumab in the treatment of chronic graft-versus-host disease (GvHD). This study will also ...

  2. A Study to Evaluate the Safety, Tolerability, and Clinical Benefit of AK002 in Adult Patients with Mast Cell Gastritis and/or Gastroenteritis

    About this study. The purpose of this study is to evaluate the safety and tolerability of AK002 in patients with mast cell gastritis and/or gastroenteritis, ...

  3. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    Prior clinical experience with CD38-targeting antibodies, including daratumumab, establish this molecule as an important therapeutic target in multiple myeloma.

  4. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    Patients with previously untreated low tumor burden indolent Non-Hodgkin's Lymphoma (NHL) will receive either rituximab or GA101 weekly for 4 weeks followed by ...

  5. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program - Mayo Clinic

    About this study. The purpose of this long-term data collection of patients with benign or malignant hematologic diseases is to collect patient demographics ...

  6. Clinical Trials - Sponson-Initiated OCS OLP-II Registry

    About this study. The purpose of this study is to collect data on the post-transplant clinical outcomes of donor livers preserved and assessed on OCS Liver ...

  7. A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients with CAA - Mayo Clinic

    The purpose of this study is to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with ...

  8. A Study of Microcirculatory Function as the Mechanism of Type 2 Myocardial Infarction - Mayo Clinic

    Also, to see if patients with T2MI without significant epicardial coronary artery disease have CMD, defined as coronary flow reserve (CFR) <2.5 or inability to ...

  9. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability, pharmaokinetics, and preliminary effectiveness of mosunetuzumab in participants with relapsed ...

  10. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...